{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:07:29Z","timestamp":1789063649046,"version":"build-2803163510"},"reference-count":84,"publisher":"BMJ","funder":[{"name":"NIHR Exeter Biomedical Research Centre","award":["NIHR203320"],"award-info":[{"award-number":["NIHR203320"]}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,8,8]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    There is a growing recognition that genetic predisposition contributes to the development of fibrotic interstitial lung disease. Adult onset monogenic disease is most commonly due to dysfunctional telomere maintenance, with a small proportion caused by surfactant biology disorders. These conditions can be associated with additional intrapulmonary and extrapulmonary features which themselves may require surveillance or treatment, making it important to make a genetic diagnosis. The recent introduction in England of a genetic testing panel accessible to respiratory physicians means that genetic information for these individuals is increasingly available but there is currently little standardisation of the subsequent management of patients and their relatives, which can be complex.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aims:<\/jats:bold>\n                    This consensus considers the causes and clinical features of familial pulmonary fibrosis and provides a suggested framework for genetic investigation and clinical management of both patients and their relatives.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Narrative:<\/jats:bold>\n                    We suggest an initial workup that may help identify those with monogenic disease, with focus on key points in the history and examination that may identify features of a telomere or surfactant biology disorder. We highlight that clinical and radiological presentations are diverse and discuss the importance of making a genetic diagnosis to inform multidisciplinary management and facilitate screening of close family members. We also discuss the many outstanding uncertainties and challenges, including the investigation and management of non-monogenic familial pulmonary fibrosis and the management of asymptomatic family members who have inherited a potentially disease-causing genetic variant.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    We suggest a pathway for the workup and management of patients with familial pulmonary fibrosis, aiming to standardise clinical care for patients and their relatives and provide a framework for the development of a national database to facilitate disease phenotyping and clinical research to improve the evidence base for clinical practice.\n                  <\/jats:p>","DOI":"10.1136\/thorax-2026-225625","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:25:32Z","timestamp":1789061132000},"page":"thorax-2026-225625","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives"],"prefix":"10.1136","author":[{"given":"Anne Ramsay","family":"Bowden","sequence":"first","affiliation":[{"name":"Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"},{"name":"Department of Genomic Medicine, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J","family":"Morris-Rosendahl","sequence":"additional","affiliation":[{"name":"Clinical Genetics and Genomics Laboratory, Royal Brompton and Harefield Hospitals, London, UK"},{"name":"Imperial College London National Heart and Lung Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[{"name":"South West Regional Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"},{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stanel","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"},{"name":"University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"},{"name":"Exeter Biomedical Research Centre, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Renzoni","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, London, UK"},{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, Imperial College London National Heart and Lung Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Chua","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, London, UK"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-5682","authenticated-orcid":false,"given":"John F","family":"Blaikley","sequence":"additional","affiliation":[{"name":"Inflammation and Repair, University of Manchester, Manchester, UK"},{"name":"Transplantation, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parfrey","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Royal Papworth Hospital, Cambridge, UK"},{"name":"University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8854-3605","authenticated-orcid":false,"given":"Nik","family":"Hirani","sequence":"additional","affiliation":[{"name":"Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK"},{"name":"Edinburgh Lung Fibrosis Clinic, Edinburgh Royal Infirmary, Edinburgh, UK"},{"name":"Rare Respiratory Disease Centre, LifeArc, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Rivera-Ortega","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"},{"name":"Rare Respiratory Disease Centre, LifeArc, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-6586","authenticated-orcid":false,"given":"Jennifer A","family":"Dickens","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Royal Papworth Hospital, Cambridge, UK"},{"name":"Rare Respiratory Disease Centre, LifeArc, London, UK"},{"name":"Cambridge Institiute for Medical Research, University of Cambridge, Cambridge, UK"},{"name":"Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091010252388000_thorax-2026-225625v1.1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01383-2022","article-title":"European Respiratory Society statement on familial pulmonary fibrosis","volume":"61","author":"Borie","year":"2023","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200408-1104OC"},{"key":"2026091010252388000_thorax-2026-225625v1.3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/resp.14650","article-title":"Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF-Next registry","volume":"29","author":"Froidure","year":"2024","journal-title":"Respirology"},{"key":"2026091010252388000_thorax-2026-225625v1.4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.202204-0781OC","article-title":"The Genetic Landscape of Familial Pulmonary Fibrosis","volume":"207","author":"Liu","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026091010252388000_thorax-2026-225625v1.5","unstructured":"National genomic test directory. n.d. Available: https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories"},{"key":"2026091010252388000_thorax-2026-225625v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"2026091010252388000_thorax-2026-225625v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0099-1"},{"key":"2026091010252388000_thorax-2026-225625v1.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013523"},{"key":"2026091010252388000_thorax-2026-225625v1.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200804-550OC"},{"key":"2026091010252388000_thorax-2026-225625v1.10","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz6876","article-title":"Determinants of telomere length across human tissues","volume":"369","author":"Demanelis","year":"2020","journal-title":"Science"},{"key":"2026091010252388000_thorax-2026-225625v1.11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50111","article-title":"Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders","volume":"7","author":"Niewisch","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026091010252388000_thorax-2026-225625v1.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PLoS One"},{"key":"2026091010252388000_thorax-2026-225625v1.13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191107","article-title":"Polygenic modifiers impact penetrance and expressivity in telomere biology disorders","volume":"135","author":"Poeschla","year":"2025","journal-title":"J Clin Invest"},{"key":"2026091010252388000_thorax-2026-225625v1.14","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2020","article-title":"Genetic disorders of the surfactant system: focus on adult disease","volume":"30","author":"van Moorsel","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2026091010252388000_thorax-2026-225625v1.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00308-2016"},{"key":"2026091010252388000_thorax-2026-225625v1.16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026091010252388000_thorax-2026-225625v1.17","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14264"},{"key":"2026091010252388000_thorax-2026-225625v1.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1646OC"},{"key":"2026091010252388000_thorax-2026-225625v1.19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00441-2023","article-title":"Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease","volume":"62","author":"Zhang","year":"2023","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03198-2020","article-title":"Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation","volume":"57","author":"Justet","year":"2021","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(18)30135-8","article-title":"Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study","volume":"6","author":"Dressen","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026091010252388000_thorax-2026-225625v1.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100333","article-title":"Telomere biology disorders in lung transplantation: Clinical challenges and management strategies","volume":"9","author":"Mesli","year":"2025","journal-title":"JHLT Open"},{"key":"2026091010252388000_thorax-2026-225625v1.23","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.jhlto.2024.100054","article-title":"Outcomes of lung transplantation in patients with telomere-related forms of progressive fibrosing interstitial lung disease pulmonary fibrosis: A systematic review","volume":"3","author":"Bordas-Martinez","year":"2024","journal-title":"JHLT Open"},{"key":"2026091010252388000_thorax-2026-225625v1.24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.healun.2025.10.027","article-title":"ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation: Authors\u2019 Perspective","volume":"45","author":"Courtwright","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"2026091010252388000_thorax-2026-225625v1.25","first-page":"0","article-title":"Mechanisms of Surfactant Maturation in Development and Disease","volume":"41","author":"Pranty","year":"2026","journal-title":"Physiology (Bethesda)"},{"key":"2026091010252388000_thorax-2026-225625v1.26","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221947"},{"key":"2026091010252388000_thorax-2026-225625v1.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0342OC"},{"key":"2026091010252388000_thorax-2026-225625v1.28","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219434"},{"key":"2026091010252388000_thorax-2026-225625v1.29","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14381"},{"key":"2026091010252388000_thorax-2026-225625v1.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2121-11-88","article-title":"A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling","volume":"11","author":"Woischnik","year":"2010","journal-title":"BMC Cell Biol"},{"key":"2026091010252388000_thorax-2026-225625v1.31","doi-asserted-by":"crossref","unstructured":"Rutherford EN , Sun D , Lim K , et al . Endogenous gene editing of alveolar organoids reveals that expression of pathogenic variant sftpc-i73t disrupts endosomal function, epithelial polarity and wound healing. Cell Biology [Preprint] 2025. doi:10.1101\/2025.07.22.665497","DOI":"10.1101\/2025.07.22.665497"},{"key":"2026091010252388000_thorax-2026-225625v1.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00217.2014"},{"key":"2026091010252388000_thorax-2026-225625v1.33","doi-asserted-by":"crossref","unstructured":"Ducrot L , Nathan N , Benusiglio PR , et al . Penetrance of interstitial lung disease and lung cancer in carriers of SFTPA1 or SFTPA2 pathogenic variants. ERJ Open Res 2025;11. doi:10.1183\/23120541.01348-2024","DOI":"10.1183\/23120541.01348-2024"},{"key":"2026091010252388000_thorax-2026-225625v1.34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01809-2023","article-title":"High risk of lung cancer in surfactant-related gene variant carriers","volume":"63","author":"Brudon","year":"2024","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20670"},{"key":"2026091010252388000_thorax-2026-225625v1.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00129414"},{"key":"2026091010252388000_thorax-2026-225625v1.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0953OC"},{"key":"2026091010252388000_thorax-2026-225625v1.38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02806-2020","article-title":"Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer","volume":"56","author":"Legendre","year":"2020","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.rdc.2023.06.005","article-title":"COPA Syndrome from Diagnosis to Treatment: A Clinician\u2019s Guide","volume":"49","author":"Simchoni","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"2026091010252388000_thorax-2026-225625v1.40","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026091010252388000_thorax-2026-225625v1.41","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0193-2020","article-title":"Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease","volume":"30","author":"Yokoyama","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2026091010252388000_thorax-2026-225625v1.42","doi-asserted-by":"crossref","DOI":"10.1002\/iub.70025","article-title":"Hermansky-Pudlak Syndrome: From Molecular Pathogenesis to Targeted Therapies","volume":"77","author":"Tondi","year":"2025","journal-title":"IUBMB Life"},{"key":"2026091010252388000_thorax-2026-225625v1.43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.rmed.2017.05.014","article-title":"Heterogeneity of lung disease associated with NK2 homeobox 1 mutations","volume":"129","author":"Nattes","year":"2017","journal-title":"Respir Med"},{"key":"2026091010252388000_thorax-2026-225625v1.44","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2502"},{"key":"2026091010252388000_thorax-2026-225625v1.45","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222060"},{"key":"2026091010252388000_thorax-2026-225625v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61214-X"},{"key":"2026091010252388000_thorax-2026-225625v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.028"},{"key":"2026091010252388000_thorax-2026-225625v1.48","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1513\/AnnalsATS.202203-267OC","article-title":"The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis","volume":"19","author":"Copeland","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026091010252388000_thorax-2026-225625v1.49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30578"},{"key":"2026091010252388000_thorax-2026-225625v1.50","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/bloodadvances.2020001721","article-title":"Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and\/or pulmonary presentations","volume":"4","author":"Feurstein","year":"2020","journal-title":"Blood Adv"},{"key":"2026091010252388000_thorax-2026-225625v1.51","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/bjh.19767","article-title":"Haematological features of telomere biology disorders diagnosed in adulthood: A French nationwide study of 127 patients","volume":"205","author":"Maillet","year":"2024","journal-title":"Br J Haematol"},{"key":"2026091010252388000_thorax-2026-225625v1.52","doi-asserted-by":"crossref","first-page":"102295","DOI":"10.1016\/j.jaut.2019.06.006","article-title":"Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging","volume":"105","author":"Meier","year":"2019","journal-title":"J Autoimmun"},{"key":"2026091010252388000_thorax-2026-225625v1.53","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1182\/bloodadvances.2025015976","article-title":"Immune cells display an abnormal maturation and a proinflammatory profile in telomere biology disorders","volume":"9","author":"Gomes","year":"2025","journal-title":"Blood Adv"},{"key":"2026091010252388000_thorax-2026-225625v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109837"},{"key":"2026091010252388000_thorax-2026-225625v1.55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508124102"},{"key":"2026091010252388000_thorax-2026-225625v1.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701009104"},{"key":"2026091010252388000_thorax-2026-225625v1.57","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0122-2016","article-title":"Management of suspected monogenic lung fibrosis in a specialised centre","volume":"26","author":"Borie","year":"2017","journal-title":"Eur Respir Rev"},{"key":"2026091010252388000_thorax-2026-225625v1.58","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00577-2022","article-title":"Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis","volume":"60","author":"Zhang","year":"2022","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.59","unstructured":"Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/08\/rare-and-inherited-disease-eligibility-criteria-v9.1.pdf"},{"key":"2026091010252388000_thorax-2026-225625v1.60","unstructured":"Available: https:\/\/nhsgms-panelapp.genomicsengland.co.uk\/panels\/1174\/v1.3"},{"key":"2026091010252388000_thorax-2026-225625v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026091010252388000_thorax-2026-225625v1.62","unstructured":"Available: https:\/\/www.acgs.uk.com\/quality\/best-practice-guidelines"},{"key":"2026091010252388000_thorax-2026-225625v1.63","unstructured":"Available: https:\/\/www.e-lfh.org.uk\/programmes\/genomics-in-the-nhs"},{"key":"2026091010252388000_thorax-2026-225625v1.64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/resp.70039","article-title":"Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis","volume":"30","author":"Franco","year":"2025","journal-title":"Respirology"},{"key":"2026091010252388000_thorax-2026-225625v1.65","doi-asserted-by":"crossref","unstructured":"Stanel S , Rivera-Ortega P . All in the family: role for precision medicine in screening and disease course prediction. In: Precision Medicine in Interstitial Lung Disease. 1st edn. Humana Cham, 2025.","DOI":"10.1007\/978-3-031-87183-2_12"},{"key":"2026091010252388000_thorax-2026-225625v1.66","unstructured":"Available: https:\/\/teamtelomere.org\/diagnosis-management-guidelines"},{"key":"2026091010252388000_thorax-2026-225625v1.67","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000490"},{"key":"2026091010252388000_thorax-2026-225625v1.68","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-025-08831-9","article-title":"Bidirectional Mendelian randomization reveals associations between telomere length and autoimmune diseases","volume":"26","author":"Jiang","year":"2025","journal-title":"Trials"},{"key":"2026091010252388000_thorax-2026-225625v1.69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515319"},{"key":"2026091010252388000_thorax-2026-225625v1.70","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1010","article-title":"Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical Trial","volume":"211","author":"Mackintosh","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026091010252388000_thorax-2026-225625v1.71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414108"},{"key":"2026091010252388000_thorax-2026-225625v1.72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503643"},{"key":"2026091010252388000_thorax-2026-225625v1.73","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2213-2600(25)00045-1","article-title":"Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation","volume":"13","author":"Alonso-Gonz\u00e1lez","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026091010252388000_thorax-2026-225625v1.74","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0135-2017","article-title":"Systematic review of drug effects in humans and models with surfactant-processing disease","volume":"27","author":"Klay","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2026091010252388000_thorax-2026-225625v1.75","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chest.2022.11.002","article-title":"Progressive Disease With Low Survival in Adult Patients With Pulmonary Fibrosis Carrying Surfactant-Related Gene Mutations: An Observational Study","volume":"163","author":"Klay","year":"2023","journal-title":"Chest"},{"key":"2026091010252388000_thorax-2026-225625v1.76","unstructured":"Available: https:\/\/www.actionpf.org\/information-support\/pf-genetics"},{"key":"2026091010252388000_thorax-2026-225625v1.77","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201909-1834OC"},{"key":"2026091010252388000_thorax-2026-225625v1.78","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1571OC"},{"key":"2026091010252388000_thorax-2026-225625v1.79","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12020674","article-title":"Optimizing Screening for Early Disease Detection in Familial Pulmonary Fibrosis (FLORIS): A Prospective Cohort Study Design","volume":"12","author":"Maus","year":"2023","journal-title":"J Clin Med"},{"key":"2026091010252388000_thorax-2026-225625v1.80","unstructured":"Available: https:\/\/clinicaltrials.gov\/study\/NCT07201922"},{"key":"2026091010252388000_thorax-2026-225625v1.81","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00019-2025","article-title":"Screening relatives of familial pulmonary fibrosis patients: who, when, how and why?","volume":"65","author":"Borie","year":"2025","journal-title":"Eur Respir J"},{"key":"2026091010252388000_thorax-2026-225625v1.82","unstructured":"Available: https:\/\/www.gov.uk\/government\/publications\/england-rare-diseases-action-plan-2025"},{"key":"2026091010252388000_thorax-2026-225625v1.83","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCRESAHA.123.322984","article-title":"Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women","volume":"133","author":"Schuermans","year":"2023","journal-title":"Circ Res"},{"key":"2026091010252388000_thorax-2026-225625v1.84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cge.70038","article-title":"Avascular Necrosis and Minimal Trauma Fractures in Telomere Biology Disorders","volume":"109","author":"Niknafs","year":"2026","journal-title":"Clin Genet"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:25:40Z","timestamp":1789061140000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":84,"alternative-id":["10.1136\/thorax-2026-225625"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225625","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}